SCHEMBL21716849

SCHEMBL21716849

c1ccc2cc3c(cc2c1)c1cc(-n2c4ccccc4c4c5ccccc5ccc42)ccc1n3-c1ccc(-c2nc3ccccc3nc2-c2ccc3c4ccccc4c4ccccc4c3c2)cc1

nearest known ligand 0.32

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGES O14684 1/20 0.32
KDM4E B2RXH2 1/20 0.31
LMNA P02545 1/20 0.31
POLB P06746 1/20 0.31
HSP90AA1 P07900 1/20 0.31
GAA P10253 1/20 0.31
MAPT P10636 1/20 0.31
PKM P14618 1/20 0.31
HTT P42858 1/20 0.31
GRK6 P43250 1/20 0.31
CYP1A2 P05177 1/20 0.30
CYP2C9 P11712 1/20 0.30
CYP2C19 P33261 1/20 0.30
F2 P00734 1/20 0.30
F10 P00742 1/20 0.30
PRSS1 P07477 1/20 0.30
MAPK8 P45983 1/20 0.30
MAPK9 P45984 1/20 0.30
MAPK10 P53779 1/20 0.30
NPY5R Q15761 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21716237 0.94 MAPK10 (0.36) PTGESKDM4ELMNAPOLBHSP90AA1
SCHEMBL21716240 0.93 L3MBTL1 (0.36) PTGESKDM4ELMNAPOLBGAA
SCHEMBL21716228 0.92 PTGES (0.32) PTGESKDM4ELMNAPOLBHSP90AA1
SCHEMBL21717535 0.92 PTGES (0.34) PTGESKDM4ELMNAPOLBHSP90AA1
SCHEMBL21716897 0.92 L3MBTL1 (0.35) PTGESKDM4ELMNAHSP90AA1GAA
SCHEMBL21716217 0.92 L3MBTL1 (0.36) KDM4ELMNAPOLBGAAF2
SCHEMBL21717100 0.92 L3MBTL1 (0.36) KDM4ELMNAPOLBGAAF2
SCHEMBL21716920 0.91 GSR (0.34) PTGESCYP1A2CYP2C9CYP2C19
SCHEMBL21717026 0.91 LMNA (0.34) PTGESKDM4ELMNAPOLBHSP90AA1
SCHEMBL21717027 0.91 HPGD (0.34) PTGESKDM4ELMNAPOLBHSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11192884-B2 Heterocyclic compound and organic light-emitting device comprising same LG CHEM, LTD. (KR) 2021-12-07 US disclosed
US-20200048226-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2020-02-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11192884-B2 Heterocyclic compound and organic light-emitting device comprising same CYP1A1, CYP1B1, CRY1 PTGES 1203/4885KDM4E 1813/4885LMNA 2047/4885
US-20200048226-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CYP1A1, CYP1B1, CRY1 PTGES 1203/4885KDM4E 1813/4885LMNA 2047/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.